Diagnostic Lab Testing Transparency Act
- Last Action
- 12/17/2024
Actions
- 2024-12-17Referred to the Subcommittee on Health.
- 2023-05-12Referred to the Subcommittee on Health.
- 2023-05-11Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-11Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2023-05-11Introduced in House
- 2023-05-11Introduced in House
CRS Summary
As of 2023-05-11 (00)
Diagnostic Lab Testing Transparency Act
This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.
Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.
Cosponsors (1)
- DIANA DEGETTE (D-CO)
Subjects
- Civil actions and liability
- Health care costs and insurance
- Medical tests and diagnostic methods
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.